224 related articles for article (PubMed ID: 35121728)
21. The basic functions of phosphoglycerate kinase 1 and its roles in cancer and other diseases.
Liu H; Wang X; Shen P; Ni Y; Han X
Eur J Pharmacol; 2022 Apr; 920():174835. PubMed ID: 35183535
[TBL] [Abstract][Full Text] [Related]
22. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth.
Nie H; Ju H; Fan J; Shi X; Cheng Y; Cang X; Zheng Z; Duan X; Yi W
Nat Commun; 2020 Jan; 11(1):36. PubMed ID: 31911580
[TBL] [Abstract][Full Text] [Related]
23. N
Liu D; Li Z; Zhang K; Lu D; Zhou D; Meng Y
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4601-4610. PubMed ID: 36171455
[TBL] [Abstract][Full Text] [Related]
24. PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma.
Ameis HM; Drenckhan A; von Loga K; Escherich G; Wenke K; Izbicki JR; Reinshagen K; Gros SJ
PLoS One; 2013; 8(12):e83701. PubMed ID: 24376734
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
26. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
[TBL] [Abstract][Full Text] [Related]
27. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.
Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
[TBL] [Abstract][Full Text] [Related]
28. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer.
Quan G; Xu J; Wang J; Liu X; Xu J; Jiang J
Cell Death Dis; 2023 Feb; 14(2):137. PubMed ID: 36807568
[TBL] [Abstract][Full Text] [Related]
29. Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy.
Fu Q; Yu Z
Life Sci; 2020 Sep; 256():117863. PubMed ID: 32479953
[TBL] [Abstract][Full Text] [Related]
30. Phosphoglycerate-kinase-1 Is a Potential Prognostic Biomarker in HNSCC and Correlates With Immune Cell Infiltration.
Wang P; Wang YY; Xu YL; Zhang CY; Wang K; Wang Q
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):723-734. PubMed ID: 38035710
[TBL] [Abstract][Full Text] [Related]
31. Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).
Wang W; Gan Z; Liu Q; Yan S; Mulati R; Wang Y
Bioengineered; 2021 Dec; 12(1):2957-2969. PubMed ID: 34180759
[TBL] [Abstract][Full Text] [Related]
32. Regulation of phosphoglycerate kinase 1 and its critical role in cancer.
Zhang K; Sun L; Kang Y
Cell Commun Signal; 2023 Sep; 21(1):240. PubMed ID: 37723547
[TBL] [Abstract][Full Text] [Related]
33. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
34. Screening Novel Drug Candidates for Kidney Renal Clear Cell Carcinoma Treatment: A Study on Differentially Expressed Genes through the Connectivity Map Database.
Gao B; Wang L; Zhang N; Han M; Zhang Y; Liu H; Sun D; Liu Y
Kidney Blood Press Res; 2021; 46(6):702-713. PubMed ID: 34818247
[TBL] [Abstract][Full Text] [Related]
35. Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression.
Li W; Yang D; Zhang Y; Zhao S; Li D; Liu M
Oncol Rep; 2020 Nov; 44(5):1985-1996. PubMed ID: 33000253
[TBL] [Abstract][Full Text] [Related]
36. LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1.
Liang J; Liu C; Xu D; Xie K; Li A
J Transl Med; 2022 Feb; 20(1):80. PubMed ID: 35123484
[TBL] [Abstract][Full Text] [Related]
37. PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process.
Xie H; Tong G; Zhang Y; Liang S; Tang K; Yang Q
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749413
[TBL] [Abstract][Full Text] [Related]
38. PGK1 represses autophagy-mediated cell death to promote the proliferation of liver cancer cells by phosphorylating PRAS40.
Zhang T; Wang Y; Yu H; Zhang T; Guo L; Xu J; Wei X; Wang N; Wu Y; Wang X; Huang L
Cell Death Dis; 2022 Jan; 13(1):68. PubMed ID: 35058442
[TBL] [Abstract][Full Text] [Related]
39. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
[TBL] [Abstract][Full Text] [Related]
40. FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect.
Chu Z; Huo N; Zhu X; Liu H; Cong R; Ma L; Kang X; Xue C; Li J; Li Q; You H; Zhang Q; Xu X
Mol Ther; 2021 Sep; 29(9):2737-2753. PubMed ID: 33940159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
